Share

Related Links

  • BWT AG
  • Elsevier Ltd is not responsible for the content of external websites.

Related Stories

Top 5 Stories

News

BWT completes takeover of Christ pharma & biotech business

07 October 2009

Austria’s BWT Group has completed the acquisition of Christ Water Technology Group’s pharmaceutical water activities including a 49% stake in the biopharma and bioprocess technology provider Zeta Group.

Two hundred employees have transferred to Christ Aqua Pharma & Biotech and will be managed by Henrik Forslund. The new organization will offer complete solutions for pure- and ultra-pure water, water for injection purposes, sterile steam, cleaning systems (CIP/SIP), pharmaceutical waste water treatment and a comprehensive range of services.

BWT says that the 49% Zeta participation offers the group an interesting future potential in the biopharma business.

 

This article is featured in:
Pharma and biotech  •  Water and Wastewater

 

Comment on this article

You must be registered and logged in to leave a comment about this article.